Whole-genome sequencing may optimize PARP inhibitor use
January 14, 2026
January 14, 2026
ITHACA, New York, Jan. 14 -- Cornell University posted the following news:
* * *
Whole-genome sequencing may optimize PARP inhibitor use
*
A whole-genome sequencing approach shows early promise over current commercial methods for identifying more patients likely to benefit from PARP inhibitor cancer treatments, according to a study led by Weill Cornell Medicine and NewYork-Presbyterian investigators. The findings suggest further development of . . .
* * *
Whole-genome sequencing may optimize PARP inhibitor use
*
A whole-genome sequencing approach shows early promise over current commercial methods for identifying more patients likely to benefit from PARP inhibitor cancer treatments, according to a study led by Weill Cornell Medicine and NewYork-Presbyterian investigators. The findings suggest further development of . . .